Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Make a selection below to explore our full database of 4 results matching: "M Shiraki"
ACE Reports
(4 Reports)
ACE Reports
Our AI driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
General Orthopaedics
The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk
Bone. 2014 Jul;64:75-81
The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk
Bone. 2014 Jul;64:75-81
Osteoarthritis
Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide
Curr Med Res Opin. 2014 May;30(5):931-6
Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide
This report has been verified by one or more authors of the original publication.
Curr Med Res Opin. 2014 May;30(5):931-6
Metabolic Disorders
Once-weekly teriparatide reduces vertebral fracture risk: Subgroup analysis from the Teriparatide Once Weekly Efficacy Research (TOWER) trial
Once-weekly teriparatide reduces vertebral fracture risk: Subgroup analysis from the Teriparatide Once Weekly Efficacy Research (TOWER) trial
Metabolic Disorders
A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study
Bone. 2011 Oct;49(4):605-12. doi: 10.1016/j.bone.2011.07.011. Epub 2011 Jul 19
A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study
This report has been verified by one or more authors of the original publication.
Bone. 2011 Oct;49(4):605-12. doi: 10.1016/j.bone.2011.07.011. Epub 2011 Jul 19